Strategic Partnerships The Catapult collaborates across academia and industry to rapid-advance cell and gene therapies, indicating opportunities to position complementary tech, manufacturing, or regulatory services to support scalable clinical-to-commercial pathways.

UK Focus With a mission to make the UK the logical hub for advanced therapies, there are sales opportunities around UK-based regulatory support, clinical development, manufacturing scale-up, and health economics expertise for both domestic and international partners.

End-to-End Capability Offering clinical trial enablement, process development, manufacturing, regulatory guidance, and market access suggests cross-sell potential for integrated solutions, including technology platforms, analytics, and compliance services.

Wind Sector Illustrations Recent collaborations in renewable energy innovation show the Catapult’s willingness to engage in cross-industry technology transfer and circular economy initiatives, presenting a pathway to introduce durable lab-to-factory hardware or data solutions applicable beyond biotech.

Financial Scale Current revenue and funding bandwidth indicate a mid-size organization open to scalable partnerships, licensing, or pilot projects with clear value capture and potential for expansion into larger multi-year programs.